Estimaciones de analistas de Wall Street para Avalo Therapeutics, Inc. (AVTX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 8 |
| Mantener | 1 |
| Venta | 1 |
| Venta fuerte | 0 |
| Analistas totales | 10 |
| Calificación media (1-5) | 0.70 |
Ratios de valoración
| Precio / Valor contable | 1.61 |
| EV / EBITDA | -9.25 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $1.2M | $27.8M | $18.3M | $6.8M | $6.7M | $5.4M | $18.1M | $1.9M | $441000 | $59000 |
| Coste de Ventas | $8.2M | $635648 | $7.5M | -$566523 | $300000 | $1.5M | $3.4M | $1.3M | -$366000 | 0 |
| Beneficio Bruto | -$7.1M | $27.2M | $10.8M | $7.3M | $6.4M | $3.9M | $14.6M | $640000 | $807000 | $59000 |
| I+D | $10.2M | $4.4M | $5.8M | $11.8M | $32.2M | $59.8M | $31.3M | $13.8M | $52.1M | $50.1M |
| Generales y Administrativos | $7.1M | $8.9M | $19.2M | $11.6M | $19.8M | $24.7M | $20.7M | $10.3M | $17.2M | $22.9M |
| Gastos Operativos | $17.2M | $13.3M | $29.5M | $23.5M | $6.4M | $86.0M | $52.1M | $28.0M | $69.3M | $73.0M |
| Beneficio Operativo | -$16.1M | $13.9M | -$39.3M | -$16.1M | 0 | -$82.1M | -$37.4M | -$27.4M | -$68.5M | -$72.9M |
| EBITDA | -$16.1M | $14.3M | -$13.1M | -$13.5M | -$45.5M | -$80.5M | -$37.3M | -$23.3M | -$34.8M | -$77.8M |
| Gastos por Intereses | $464181 | $24016 | 0 | 0 | 0 | $2.4M | $4.2M | $3.4M | 0 | 0 |
| Beneficio Antes de Impuestos | -$16.5M | $13.8M | -$40.1M | -$16.0M | -$67.2M | -$84.5M | -$41.6M | -$31.5M | -$35.0M | -$78.1M |
| Impuestos | $364144 | $2.0M | -$33910 | $280316 | -$2.8M | -$196000 | $28000 | $14000 | $114000 | $165000 |
| Beneficio Neto | -$16.5M | $11.9M | -$40.1M | -$16.1M | -$63.5M | -$84.4M | -$41.7M | -$31.5M | -$35.1M | -$78.3M |
| BPA | $-21.93 | $1856.88 | $-3317.28 | $-819.74 | $-2523.77 | $-2330.66 | $-1062.65 | $-113.58 | $-4.32 | $-5.84 |
| BPA Diluido | $-21.93 | $1822.74 | $-3317.28 | $-819.74 | $-2523.77 | $-2330.66 | $-1062.65 | $-113.58 | $-3.26 | $-5.84 |
| Acciones en Circulación (Diluidas) | $3066 | $6512 | $12074 | $19849 | $25511 | $36191 | $39202 | $277727 | $10.8M | $13.4M |
Precio
| Precio | $16.58 |
| Capitalización | $872M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: AARD · BDTX · CHRS · CRBU · ENTA · EPRX · IVA
Explorar sector: Healthcare · Biotechnology
Más secciones de AVTX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones